On respiratory impairment in cancer cells.

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev (1998) 12.48

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell (2006) 11.79

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A (2008) 11.71

Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43

The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81

Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity (2011) 5.43

Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol Biol Cell (2007) 4.27

4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell (2009) 4.20

With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab (2010) 4.11

Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc Natl Acad Sci U S A (2009) 3.57

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol (2007) 3.51

Role of autophagy in cancer: management of metabolic stress. Autophagy (2007) 3.40

Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci U S A (2011) 3.39

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A (2005) 3.18

Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis (2013) 3.07

Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 3.03

Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med (2011) 2.97

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med (2011) 2.93

SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell (2011) 2.73

Metabolic catastrophe as a means to cancer cell death. J Cell Sci (2007) 2.58

Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle (2012) 2.55

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci U S A (2009) 2.55

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr (2007) 2.47

Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A (2008) 2.41

Metabolic regulation by p53. J Mol Med (Berl) (2011) 2.26

Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J Biol Chem (2011) 2.24

Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med (2009) 2.13

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11

Cancer metabolism: current perspectives and future directions. Cell Death Dis (2012) 2.07

Metabolism of [U-13 C]glucose in human brain tumors in vivo. NMR Biomed (2012) 2.06

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal (2012) 2.05

13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab (2011) 2.05

Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev (2012) 2.03

A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther (2008) 2.03

Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00

Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene (2009) 1.99

Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat Rev Immunol (2014) 1.96

Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer (2013) 1.93

The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res (2009) 1.92

Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet (2011) 1.90

Metabolic Heterogeneity in Human Lung Tumors. Cell (2016) 1.86

Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer (2010) 1.84

A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med (2009) 1.84

Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res (2008) 1.83

Acetate dependence of tumors. Cell (2014) 1.80

Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat Cell Biol (2011) 1.76

The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One (2009) 1.75

Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest (2013) 1.72

K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res (2011) 1.72

Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A (2009) 1.72

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet (2012) 1.70

A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging (Albany NY) (2010) 1.70

Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene (2010) 1.68

Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim Biophys Acta (2009) 1.67

Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Comput Biol (2011) 1.66

Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci U S A (2010) 1.65

Autophagy and disease: always two sides to a problem. J Pathol (2011) 1.64

CD133 is a marker of bioenergetic stress in human glioma. PLoS One (2008) 1.63

mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest (2010) 1.61

Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. J Med Chem (2010) 1.61

c-Myc and cancer metabolism. Clin Cancer Res (2012) 1.60

Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 1.60

The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood (2012) 1.60

Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer (2013) 1.57

Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol (2013) 1.57

The metabolic life and times of a T-cell. Immunol Rev (2010) 1.57

Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer (2014) 1.55

New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54

Mitochondrial subversion in cancer. Cancer Prev Res (Phila) (2011) 1.54

Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells. Nat Protoc (2012) 1.54

Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol (2010) 1.54

Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol Syst Biol (2012) 1.54

Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One (2009) 1.52

Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta (2010) 1.50

Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50

Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med (2008) 1.50

Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem (2010) 1.49

Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care (2013) 1.49

Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc Natl Acad Sci U S A (2009) 1.48

Mitochondrial dynamics in diabetes. Antioxid Redox Signal (2010) 1.46

Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J (1987) 1.45

Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol (2003) 1.45

Autophagy in stem cells. Autophagy (2013) 1.43

Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int (2016) 1.42

Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res (2009) 1.42

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther (2010) 1.42

Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta (2009) 1.41

Somatic mutations in aging, cancer and neurodegeneration. Mech Ageing Dev (2011) 1.39

Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis (2013) 1.38

Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg Med Chem Lett (2010) 1.37

Hypoxia, glucose metabolism and the Warburg's effect. J Bioenerg Biomembr (2007) 1.37

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun (2015) 1.36

Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle (2011) 1.36

IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin Cancer Res (2012) 1.36

Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) (2011) 1.35

Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res (2011) 1.35

Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet (2010) 1.34

On the origin of cancer cells. Science (1956) 49.55

[Glycolic acid formation in Chlorella]. Z Naturforsch B (1960) 2.34

An electrochemical demonstration of the energy cycle and maximum quantum yield in photosynthesis. Biochim Biophys Acta (1954) 1.93

The maximum efficiency of photosynthesis. Arch Biochem (1950) 1.81

[THE QUANTITATIVE CHEMISTRY OF PHOTOSYNTHESIS, AUTOMATICALLY RECORDED]. Biochem Z (1964) 1.67

ANNUAL REVIEW OF BIOCHEMISTRY. PREFATORY CHAPTER. Annu Rev Biochem (1964) 1.53

[Origin of cancer cells]. Oncologia (1956) 1.52

[Not Available]. Z Naturforsch B (1958) 1.41

[The necessity of carbon dioxide for quinone and ferricyanide reactions in green grain]. Z Naturforsch B (1960) 1.27

[Further development of manometric methods (carbonate mixtures)]. Z Naturforsch B (1960) 1.16

[Determination of the quantum requirements for photosynthesis by very thin cell suspensions]. Biochim Biophys Acta (1954) 1.03

The quantum efficiency of photosynthesis. Biochim Biophys Acta (1950) 1.01

Photosynthesis. Science (1958) 1.00

[Metabolism of leukocytes]. Z Naturforsch B (1958) 0.92

[On the facultative anaerobiosis of cancer cells and its use in chemotherapy]. Munch Med Wochenschr (1961) 0.90

[The 1-vessel method for measurement of the quantum requirement in photosynthesis]. Z Naturforsch B (1960) 0.90

[A new determination of the quantum requirement of photosynthesis with the compensation method]. Z Naturforsch B (1960) 0.90

[Partial anaerobiosis and radiation-sensitivity of cancer cells]. Arch Biochem Biophys (1958) 0.88

Further development of manometric methods. J Natl Cancer Inst (1960) 0.87

[Manometric x-ray actinometer and the effect of x-rays on the fermentation of cancer cells]. Z Naturforsch B (1958) 0.86

[Measurement of energy metabolism in photosynthesis by means of a large-surface bolometer]. Biochim Biophys Acta (1955) 0.86

A manometric actinometer for the visible spectrum. Arch Biochem (1949) 0.86

[EXPERIMENTS ON ANAEROBIOSIS OF CANCER CELLS]. Klin Wochenschr (1965) 0.81

[The effect of hydrogen peroxide on cancer cells and on embryonic cells]. Acta Unio Int Contra Cancrum (1958) 0.79

[On the chemical mechanism of photosynthesis]. Z Naturforsch B (1959) 0.79

[The reaction of ascites tumor cells to oxygen under high pressure]. Arch Geschwulstforsch (1953) 0.77

Assimilatory quotient and photochemical yield. Am J Bot (1948) 0.77

[Further development of manometric methods]. Z Naturforsch B (1960) 0.77

[On the transformation of embryonal metabolism into cancer metabolism]. Hoppe Seylers Z Physiol Chem (1960) 0.75

[On phosphorylation in light]. J Gen Physiol (1962) 0.75

[ON THE BEHAVIOR OF ASPARAGINIC ACID AND ALANINE IN CHLORELLA, STUDIED WITH OPTICAL TESTS]. Biochem Z (1964) 0.75

[Cytodeuteroporphyrin]. Hoppe Seylers Z Physiol Chem (1953) 0.75

[Effect of carbon monoxide on respiration and photosynthesis in green cotyledons]. Z Naturforsch B (1960) 0.75

[ON DESTRUCTION OF CANCER CELLS WITH ROENTGEN RAYS]. Z Naturforsch B (1963) 0.75

[Further development of the cellular physiological methods. Association of manometry and optical lactic acid determination]. Hoppe Seylers Z Physiol Chem (1960) 0.75

[Not Available]. Strahlentherapie (1956) 0.75

[Catalase content, fermentation and respiration in cell culture after Dulbecco-Vogt trypsinization]. Z Naturforsch B (1958) 0.75

[CHEMISTRY OF PHOTOSYNTHESIS]. Z Naturforsch B (1963) 0.75

Does light inhibit the respiration of green cells? Arch Biochem (1949) 0.75

[CHEMISTRY OF PHOTOSYNTHESIS]. Bull Soc Chim Biol (Paris) (1964) 0.75

[On the effect of roentgen rays on hemoglobin (with a remark on the radiosensitivity of tissue sections)]. Z Naturforsch B (1960) 0.75

[The transformation of embryonal metabolism in cancer metabolism]. Z Naturforsch B (1960) 0.75

[Not Available]. Z Naturforsch B (1958) 0.75

[Further development of manometric methods (oxygen absorption by chromium chloride)]. Z Naturforsch B (1962) 0.75

[Further development of manometric methods (measurement of autoxidation)]. Z Naturforsch B (1962) 0.75

[GERHARD DOMAGK]. Dtsch Med Wochenschr (1965) 0.75

[Metabolism of embryonal cells in tissue culture]. Biochim Biophys Acta (1957) 0.75

[THE CHEMICAL REACTIONS OF PHOTOSYNTHESIS]. Hoppe Seylers Z Physiol Chem (1963) 0.75

[Cytohemin from the heart muscle]. Hoppe Seylers Z Physiol Chem (1951) 0.75

[Further development of manometric methods]. Z Naturforsch B (1958) 0.75